Ambey Laboratories IPO: Review, Complete Analysis

Ambey Laboratories IPO is an SME book-built issue of 65.70 lacs Shares amounting up to Rs.44.68 crore with a combination of OFS of 3.12 lacs Shares of Rs.2.12 crore and a Fresh Issue of 62.58 lacs Shares of Rs.42.55 crore out of which 35% is allocated to retail investors, 50% to institutional investors, and 15% to non-institutional investors. The IPO will be available to investors on July 04, 2024, and conclude on July 08, 2024. The IPO will take place on the NSE and SME, with a projected listing date of Thursday, July 11, 2024. The price band of the share is Rs.65 to Rs.68 for each Share.

sonu sonu
Jun 29, 2024 - 17:17
1668

Share this Post to earn Money ( Upto ₹100 per 1000 Views )


Ambey Laboratories IPO: Review, Complete Analysis

Ambey Laboratories IPO 

Ambey Laboratories, established in 1985, specializes in agrochemical production for crop protection. With ISO 9001:2015 and ISO 14001:2015 certifications, the company serves major clients and plans to launch its IPO on July 4, 2024.

IPO Details

  • Issue Size: 65.70 lakh shares, totaling Rs. 44.68 crore

  • Components: OFS of 3.12 lakh shares (Rs. 2.12 crore) and Fresh Issue of 62.58 lakh shares (Rs. 42.55 crore)

  • Price Band: Rs. 65 to Rs. 68 per share

  • Listing: NSE and SME

  • Reservation: 50% for institutional investors, 35% for retail, and 15% for non-institutional investors

  • Timetable:

    • Opening Date: July 4, 2024

    • Closing Date: July 8, 2024

    • Listing Date: July 11, 2024

Objectives of the Issue

  • Meeting working capital requirements

  • General corporate purposes

  • Covering issue-related expenses

Strengths

  • Skilled management

  • Strategic manufacturing location

  • Quality assurance and standards

  • Strong vendor relationships

Weaknesses

  • Frozen promoter's demat account by SEBI

  • Dependence on leased properties

  • Hazardous material handling risks

  • Potential deviation in estimated costs

Ambey Laboratories shows growth in revenue and assets despite a decline in EBITDA. The upcoming IPO aims to support various corporate goals. Investors should consider financial performance and risk factors before investing.

Click Here To Apply & Know More About Ambey Laboratories IPO

Click Here To See More   

Tags: